Select Author

InsideAccess: Minimizing Errors and Saving Time in Drug Receipt Processes

The speed-accuracy trade-off is a well-known phenomenon in psychology for processes requiring human input: the faster you go, the more likely it is that errors will be introduced into the system. This presents a major challenge for complex supply chains that demand both efficiency and accuracy. For example, when handling and distributing sensitive clinical materials, it is essential that the workflow proceed as quickly as possible while minimizing errors.

Topic: Biobanking and Biorepository, Content: Insi..........

Case Studies in Supply Chain Management: Getting it Right From the Start Part 1, Planning for Autologous Therapies

Consistent management and communication are the keys to success when managing the supply chain of any advanced therapy clinical trial. In this two part blog series I’ll review two case studies that demonstrate the importance of supply chain management by focusing on scaling up for commercial distribution and on packaging challenges within a cryogenic environment.

Topic: Cold-Chain Logistics, Topic: Qualification ..........

World AIDS Day 2017

December 1st is World AIDS Day. Each year, this day is an opportunity to raise awareness of the AIDS pandemic, unite in the fight against HIV, and remember those lost to an AIDS-related illness. The 2017 World AIDS Day theme is “Increasing Impact through Transparency, Accountability, and Partnerships”. This theme reflects a shift in attitude from crisis toward control, and the role of partnerships in reaching our collective goals.

Topic: Biobanking and Biorepository, Topic: Public..........

Transitioning to a New Biobank Model at a Time of Change: An AstraZeneca & Fisher BioServices Perspective

The AstraZeneca (AZ) UK Biobank offers long-term storage of, and rapid access to, ~1 million human biological samples (HBS) from AZ Oncology clinical trials, collaborators and commercial sources. A variety of sample types are managed including normal tissue, tumor tissue, blood/plasma/serum, urine and other excreta, FFPE blocks, glass slides and genetic samples (DNA/blood).

Topic: Biobanking and Biorepository, Content: Post..........

Determining Optimum Maintenance Temperature for Advanced Therapies, Part 1

As referenced in a previous blog post, understanding the proper method of safely cryopreserving your material is essential, but of equal importance is determining the optimum maintenance temperature. There are many factors that need to be considered when selecting an effective maintenance temperature. Those factors include volume, handling processes, storage and handling equipment and the impact of multiple short duration exposures. In this two part blog series, we’ll discuss four areas that need to be understood to determine the optimum maintenance temperature for advanced therapy material.

Topic: Biobanking and Biorepository, Topic: Cold-C..........

24 Hours of Stem Cells

Stem cell research is one of the fastest growing areas in science. This is largely due to its immense potential to impact the future of medicine and how we treat diseases. Whether in basic research or advanced therapy applications, Fisher BioServices is committed to the expansion of this field. To facilitate knowledge sharing and collaboration, Thermo Fisher Scientific is hosting the 5th Annual 24 Hours of Stem Cells event - the day the world revolves around stem cells.

Topic: Cell Therapy Solutions, Content: Blog

Scaling the Advanced Therapy Supply Chain

Treating castration resistant prostate cancer means that failure within the advanced therapy supply chain has a catastrophic impact on patients.

Topic: Cold-Chain Logistics, Topic: Cell Therapy S..........

Distributed Biobanking: An End to End Solution for FFPE Tissue Block Management

The process of formalin-fixed paraffin-embedding (FFPE) emerged in the late 19th century as a valuable histological method for stabilizing and preserving the morphology and cellular details of tissue samples. Additional advantages of preserving  tissues using the FFPE technique included long term room temperature storage without fear of degradation, and if tissues were correctly preserved, FFPE blocks could be used over decades to prepare additional slides for microscopic analysis (as long as there was remaining tissue in the paraffin block) with little or no tissue degradation. Significant advances in protein and nucleic acid isolation techniques from FFPE tissues have resulted in the generation of sufficient amounts of nucleic acid which can be used in a wide range of analytical techniques for the determination of structure and function of these key biological molecules.

Topic: Biobanking and Biorepository, Topic: Labora..........

The Effect of Pre-analytical Variables on Plasma Samples Stored in Biobanks

Differences detected in respective biospecimen collections are more dependent on pre-analytical variables than on the inherent differences among the samples. Therefore, there is a parallel emphasis on standard protocol for biological sample collection and storage and identifying specific biomarkers as quality controls to assess the effects of pre-analytical factors on variability in the results. Mateos et al. (2016) used different, complementary proteomic techniques in separate, coordinated laboratories to search for quality biomarkers that would allow assessment of integrity and purity of plasma samples stored in biobanks.1

Topic: Biobanking and Biorepository, Topic: Labora..........

Cell & Gene Meeting on the Mesa 2017

The advancements in advanced therapy are increasing at a rapid pace and are transforming the way we think about medicine. Whether in research or in the clinic, scientific innovators are acutely aware that every moment counts when working with these valuable therapies. To facilitate knowledge sharing and collaboration, we are pleased to announce our participation as a gold sponsor at the Cell & Gene Meeting on the Mesa in La Jolla, California.

Topic: Cell Therapy Solutions, Content: Blog

Optimizing Advanced Therapy Supply Chain Design to Ensure Commercial Success

The advanced therapy supply chain is complex and made up of multiple moving parts. With milestone achievements such as the recent FDA approval of Novartis' CAR-T cell therapy Kymriah™ it's essential that we address the challenges of delivering these ground breaking therapies to patients on a global scale.

Topic: Cold-Chain Logistics, Content: Webinar, Top..........

Halting the Next Ebola Epidemic

Prior to 2014 Ebola was mostly seen as a deadly disease, but contained in remote areas of the world with a low likelihood of spreading. However, this false impression was dispelled when the disease hit heavily populated urban areas. Suddenly the world realized the Ebola outbreaks could reach epidemic proportions, and with an average fatality rate of approximately 50%, the potential impact could be catastrophic. In response, the scientific community rushed to develop a vaccine.

Topic: Biobanking and Biorepository, Topic: Public..........